The Role of 18F-FDG PET/CT in Lung Cancer

Abstract

Lung Cancer is a common disease and the leading cause of cancer-related death in many countries. Early detection of lung cancer is essential for early therapeutic interventions which can reduce mortality. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of new pulmonary carcinoma diagnosis. Positron emission tomography (PET/CT), combining anatomic information of CT and metabolic information of PET. 18F-fluorodeoxyglucose (18F-FDG) is the most widely used radionuclide in oncology. PET/CT has been shown to be useful for evaluating an indeterminate pulmonary nodule, staging mediastinal lymph nodes, and evaluating local nodal and distant metastases.Key words: PET/CT, 18F-FDG, Lung Cancer